Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


Term:immunodeficiency with hyper IgM type 3
go back to main search page
Accession:DOID:0060023 term browser browse the term
Definition:A hyper IgM syndrome that has_material_basis_in mutation in the TNFRSF5 gene, resulting in type 3 hyper-IgM immunodeficiency that is characterized by an inability of B cells to undergo isotype switching, an inability to mount an antibody-specific immune response, and a lack of germinal center formation. (DO)
Synonyms:exact_synonym: CD40 deficiency;   HIGM3;   HIGM3 syndrome;   Hyper IgM Immunodeficiency Syndrome Type 3;   hyper IgM syndrome 3;   hyper-IgM syndrome due to CD40 deficiency;   type 3 hyper-IgM immunodeficiency
 primary_id: OMIM:606843
 alt_id: RDO:9004189
 xref: ORDO:101090
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants       view all columns           Sort by:
immunodeficiency with hyper IgM type 3 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Cd40 CD40 molecule JBrowse link 3 161,519,789 161,534,943 RGD:8554872

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15625
    syndrome 5162
      primary immunodeficiency disease 956
        combined T cell and B cell immunodeficiency 66
          immunodeficiency with hyper IgM type 3 1
Path 2
Term Annotations click to browse term
  disease 15625
    disease of anatomical entity 14954
      Immune & Inflammatory Diseases 3099
        immune system disease 2520
          primary immunodeficiency disease 956
            B cell deficiency 77
              selective immunoglobulin deficiency disease 25
                dysgammaglobulinemia 25
                  hyperimmunoglobulin syndrome 16
                    hyper IgM syndrome 4
                      immunodeficiency with hyper IgM type 3 1
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.